There are many different types of Chronic Liver Disease (CLD).
Non-Alcoholic Fatty Liver Disease/Non-Alcoholic SteatoHepatitis (NAFLD/NASH)
Alcohol Liver Disease (ALD)
Hepatitis C (HCV)
Hepatitis B (HBV)
Primary Biliary Cholangitis (PBC)
… and other forms of CLD all cause liver injury and chronic inflammation which leads progressive liver fibrosis/cirrhosis in CLD patients.
CLD disrupts the metabolism of the CLD patient. These metabolic alterations create an increased demand for certain metabolites that normal healthy people do not experience. These unique metabolic demands create new distinctive nutritional requirements for patients with CLD. CLD patients cannot satisfy these new nutritional requirements with regular diet modification alone.
A medical food for CLD patients must strategically identify, coordinate and supply both the proper amount and proper balance of metabolites necessary to fulfill the new distinctive nutritional requirements of CLD patients. Disrupted CLD-associated metabolic pathways (1,6) are listed below:
The CLD-related metabolic alterations listed above involve up-regulation and increased cycling of metabolites involved in the following biosynthetic pathways (1,2,3,4,5,6):
HepAssure medical food satisfies the new distinctive nutritional requirements for Patients with CLD by supplying metabolites involved in CLD-altered metabolic pathways in appropriate quantities and proportion.